NKE vs RXST · P/E 35, rev $46.40B vs rev $64.6M
Nike Inc (NKE) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. Revenue was up 0.2% from 2025-05-31 to 2026-05-31. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Latest reported RXST revenue for 2026-06-30 was $64.6M. Net income was -$28.0M. RXST currently screens at market cap $198.3M.
NKE currently screens at market cap $110.14B and trailing P/E 34.6. RXST currently screens at market cap $198.3M.
Not investment advice. Open the NKE and RXST stock pages for the full models.
Not investment advice.